These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12117973)

  • 1. Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.
    Bruss JB; Siber GR
    Infect Immun; 2002 Aug; 70(8):4600-8. PubMed ID: 12117973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H; Sato Y
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model.
    Bruss JB; Siber GR
    Clin Diagn Lab Immunol; 1999 Jul; 6(4):464-70. PubMed ID: 10391844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system.
    Sato H; Sato Y
    Infect Immun; 1984 Nov; 46(2):415-21. PubMed ID: 6542069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis vaccine: a critique.
    Robbins JB; Schneerson R; Keith JM; Miller MA; Kubler-Kielb J; Trollfors B
    Pediatr Infect Dis J; 2009 Mar; 28(3):237-41. PubMed ID: 19165133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP.
    Robbins JB; Schneerson R; Keith JM; Shiloach J; Miller M; Trollors B
    Vaccine; 2007 Apr; 25(15):2811-6. PubMed ID: 17291636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.
    Kamachi K; Konda T; Arakawa Y
    Vaccine; 2003 Nov; 21(31):4609-15. PubMed ID: 14575775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
    Kimura A; Mountzouros KT; Relman DA; Falkow S; Cowell JL
    Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection.
    Fry SR; Chen AY; Daggard G; Mukkur TKS
    J Med Microbiol; 2008 Jan; 57(Pt 1):28-35. PubMed ID: 18065664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
    Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Specificity Following a Recent
    Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
    Front Immunol; 2019; 10():1364. PubMed ID: 31275314
    [No Abstract]   [Full Text] [Related]  

  • 15. Aerosol infection test for evaluation of pertussis vaccine.
    Syukuda Y; Watanabe H; Suehara A; Fujii S; Kuno-Sakai H; Kimura M
    Tokai J Exp Clin Med; 1988; 13 Suppl():71-7. PubMed ID: 2908529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acellular pertussis vaccine].
    Wiedermann G; Ambrosch F; Vanura H
    Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between structure and biological and protective activities of pertussis toxin.
    Sato H; Sato Y
    Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acellular and whole cell pertussis vaccines protect against the lethal effects of intracerebral challenge by two different T-cell dependent humoral routes.
    Wiertz EJ; Walvoort HC; Van Loveren H; Van Straaten-Van De Kappelle I; Van Der Gun JW; Kreeftenberg JG
    Biologicals; 1990 Jul; 18(3):173-80. PubMed ID: 2257130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo.
    Xing DK; Canthaboo C; Corbel MJ
    Vaccine; 2000 Apr; 18(20):2110-9. PubMed ID: 10715525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.